Ms. Maike Langini
Currently, Maike is working at Medicines Discovery Catapult on a collaborative study with LifeArc focused on applying mass spectrometry-based proteomics in the field of drug discovery. She is finishing her PhD in chemistry at the Heinrich Heine University Düsseldorf with Prof Kai Stühler. Previous research focused on lncRNA based perturbations of protein signatures in brain tumours, secretome analysis in cancer cell lines, tumour tissue proteomics and phospho-proteomics.
Since 2017, Maike has been working with the Young Proteomics Investigators Club (YPIC) the early career researcher group of EuPA and was elected as their president in 2020.